Disease Stage Qualifier
	BCLC Stage
	CNS Leukemia at Diagnosis
		CNS1
		CNS2
			CNS 2a
			CNS 2b
			CNS 2c
		CNS3
			CNS 3a
			CNS 3b
			CNS 3c
	FIGO Stage
		FIGO Stage 0
		FIGO Stage I
			FIGO Stage IA
				FIGO Stage IA1
				FIGO Stage IA2
			FIGO Stage IB
				FIGO Stage IB3
				FIGO Stage IB1
				FIGO Stage IB2
			FIGO Stage IC
				FIGO Stage IC1
				FIGO Stage IC2
				FIGO Stage IC3
		FIGO Stage II
			FIGO Stage IIA
				FIGO Stage IIA1
				FIGO Stage IIA2
			FIGO Stage IIB
		FIGO Stage III
			FIGO Stage IIIA
				FIGO Stage IIIA1
					FIGO Stage IIIA1(i)
					FIGO Stage IIIA1(ii)
				FIGO Stage IIIA2
			FIGO Stage IIIB
			FIGO Stage IIIC
				FIGO Stage IIIC1
				FIGO Stage IIIC2
		FIGO Stage IV
			FIGO Stage IVA
			FIGO Stage IVB
	AJCC v8 Stage
		Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8 Stage
		Differentiated Thyroid Gland Carcinoma 55 Years and Older AJCC v8 Stage
	AIDS-Related Kaposi Sarcoma Stage
		AIDS-Related Kaposi Sarcoma T (Tumor) Status
			AIDS-Related Kaposi Sarcoma T0 (Good Risk): Localized Tumor
				AIDS-Related Kaposi Sarcoma T0 (Good Risk): Skin and/or Lymph Nodes
				AIDS-Related Kaposi Sarcoma T0 (Good Risk): Minimal Oral Disease
			AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Widespread Tumor
				AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Edema or Ulceration
				AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Extensive Oral Involvement
				AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Gastrointestinal Tract Involvement
				AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Pulmonary Involvement
				AIDS-Related Kaposi Sarcoma T1 (Poor Risk): Other Non-Nodal Viscera Involvement
		AIDS-Related Kaposi Sarcoma I (Immune System) Status
			AIDS-Related Kaposi Sarcoma I0 (Good Risk)
			AIDS-Related Kaposi Sarcoma I1 (Poor Risk)
		AIDS-Related Kaposi Sarcoma S (Systemic Illness) Status
			AIDS-Related Kaposi Sarcoma S0 (Good Risk)
			AIDS-Related Kaposi Sarcoma S1 (Poor Risk)
		AIDS-Related Kaposi Sarcoma Overall Risk Group
			AIDS-Related Kaposi Sarcoma Good Risk
			AIDS-Related Kaposi Sarcoma Poor Risk
	Durie/Salmon Stage
	International Staging System Stage
	Breast Cancer Anatomic Stage
	Breast Cancer Prognostic Stage
	Stage R
		Stage R0
		Stage R1
		Stage R2
		Stage RX
	Whitmore-Jewett Stage
	ENSAT Stage
	Ann Arbor Stage
	Lugano Stage
	Stage IE
	Stage IIE
	Rai Stage
	Binet Stage
		Binet Stage A
		Binet Stage B
		Binet Stage C
	St. Jude Stage
	RISS Stage
	Occult Stage
	Masaoka-Koga Stage
	Mediastinal Malignant Germ Cell Tumor Stage
	Staging Incomplete
		Incomplete Staging (cM)
		Incomplete Staging (pM)
	Stage I
		Stage IA
			Stage IA3
			Stage IA1
			Stage IA2
		Stage IB
			Stage IB Cervix
				Stage IB1
				Stage IB2
		Stage IC
	Stage III
		Stage IIID
		Stage IIIA
			Stage IIIA1
			Stage IIIA2
		Stage IIIB
		Stage IIIC
			Stage IIIC1
			Stage IIIC2
	Stage IV
		Stage IVS
		Stage IVA
			Stage IVA1
			Stage IVA2
		Stage IVB
		Stage IVC
	Stage V
	Stage 0
		Stage 0a
		Stage 0is
	Stage II
		Stage IIA
			Stage IIA Cervix
				Stage IIA1
				Stage IIA2
		Stage IIB
		Stage IIC
		Stage II Cervix
			Stage IIA Cervix
				Stage IIA1
				Stage IIA2
	Stage A
	Stage B
		Stage B1
		Stage B2
	Stage C
	Stage D
		Stage D1
		Stage D2
	Extensive Stage
	Limited Stage
	Stage Unspecified
	Hepatoblastoma Stage
		Postsurgical Stage I
		Postsurgical Stage II
		Postsurgical Stage III
		Postsurgical Stage IV
		PRETEXT Stage 1
		PRETEXT Stage 2
		PRETEXT Stage 3
		PRETEXT Stage 4
	Stage Is
	AJCC v6 Stage
	AJCC v7 Stage
		Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7 Stage
		Differentiated Thyroid Gland Carcinoma 45 Years and Older AJCC v7 Stage
	Stage Unknown
	Advanced Stage
	Stage X
